Yu-Min Yeh

2024

Germline MLH1 and MSH6 mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case report

Huang, Y. C., Lin, P. C., Wu, P. Y., Chen, N. S., Shen, M. R., Yeh, Y. M. & Cheng, Y. M., 2024 6月, 於: Gynecologic Oncology Reports. 53, 101381.

研究成果: Article › 同行評審

開啟存取

Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition

Huang, Y. T., Hsu, Y. T., Wu, P. Y., Yeh, Y. M., Lin, P. C., Hsu, K. F. & Shen, M. R., 2024 12月, 於: Journal of Experimental and Clinical Cancer Research. 43, 1, 65.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

2023

Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours

Yen, C. C., Yeh, Y. M., Huang, H. Y., Ting, Y. L., Fu, P. A., Lin, T. C., Liu, I. T. & Yen, C. J., 2023 7月, 於: Targeted Oncology. 18, 4, p. 611-623 13 p.

研究成果: Article › 同行評審

開啟存取

Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers

Li, C. I., Yeh, Y. M., Tsai, Y. S., Huang, T. H., Shen, M. R. & Lin, P. C., 2023 12月, 於: Human Genomics. 17, 1, 18.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Distinct Features of Plasma Ultrashort Single-Stranded Cell-Free DNA as Biomarkers for Lung Cancer Detection

Cheng, J., Swarup, N., Li, F., Kordi, M., Lin, C. C., Yang, S. C., Huang, W. L., Aziz, M., Kim, Y., Chia, D., Yeh, Y. M., Wei, F., Zheng, D., Zhang, L., Pellegrini, M., Su, W. C. & Wong, D. T. W., 2023 11月 1, 於: Clinical Chemistry. 69, 11, p. 1270-1282 13 p.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer

Lee, C. T., Chu, C. A., Wang, Y. M., Wang, Y. W., Chen, Y. L., Ho, C. L., Yeh, Y. M., Lin, P. C., Lin, B. W., Chen, P. C., Chen, S. H., Chan, R. H., Chang, C. & Chow, N. H., 2023 7月, 於: Molecular Carcinogenesis. 62, 7, p. 951-962 12 p.

研究成果: Article › 同行評審

2 引文斯高帕斯（Scopus）

HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study

Chen, P. C., Yeh, Y. M., Chu, C. T., Su, P. F., Chiu, P. H., Lin, B. W., Chen, S. H., Lin, P. C., Lee, C. T., Chen, H. H. W. & Chen, C. C., 2023 3月, 於: European Journal of Cancer. 181, p. 62-69 8 p.

研究成果: Article › 同行評審

12 引文斯高帕斯（Scopus）

2022

Adjusted CT Image-Based Radiomic Features Combined with Immune Genomic Expression Achieve Accurate Prognostic Classification and Identification of Therapeutic Targets in Stage III Colorectal Cancer

Huang, Y. C., Tsai, Y. S., Li, C. I., Chan, R. H., Yeh, Y. M., Chen, P. C., Shen, M. R. & Lin, P. C., 2022 4月 1, 於: Cancers. 14, 8, 1895.

研究成果: Article › 同行評審

開啟存取

8 引文斯高帕斯（Scopus）

A Prediction Model for Tumor Recurrence in Stage II–III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling

Chen, P. C., Yeh, Y. M., Lin, B. W., Chan, R. H., Su, P. F., Liu, Y. C., Lee, C. T., Chen, S. H. & Lin, P. C., 2022 2月, 於: Biomedicines. 10, 2, 340.

研究成果: Article › 同行評審

開啟存取

10 引文斯高帕斯（Scopus）

CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer

Hsieh, C. C., Hsu, S. H., Lin, C. Y., Liaw, H. J., Li, T. W., Jiang, K. Y., Chiang, N. J., Chen, S. H., Lin, B. W., Chen, P. C., Chan, R. H., Lin, P. C., Yeh, Y. M. & Shen, C. H., 2022 11月 1, 於: British Journal of Cancer. 127, 9, p. 1615-1628 14 p.

研究成果: Article › 同行評審

開啟存取

16 引文斯高帕斯（Scopus）

PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment

Chung, B. S., Liao, I. C., Lin, P. C., Wu, S. Y., Kang, J. W., Lin, B. W., Chen, P. C., Chan, R. H., Lee, C. T., Shen, M. R., Chen, S. H. & Yeh, Y. M., 2022 11月, 於: International journal of molecular sciences. 23, 21, 13277.

研究成果: Article › 同行評審

開啟存取

9 引文斯高帕斯（Scopus）

The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer

Chan, R. H., Chen, P. C., Yeh, Y. M., Lin, B. W., Yang, K. D., Shen, M. R. & Lin, P. C., 2022 2月, 於: Diagnostics. 12, 2, 315.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

2021

Association between altered oncogenic signaling pathways and overall survival of patients with metastatic colorectal cancer

Huang, Y. H., Lin, P. C., Su, W. C., Chan, R. H., Chen, P. C., Lin, B. W., Shen, M. R., Chen, S. H. & Yeh, Y. M., 2021 12月, 於: Diagnostics. 11, 12, 2308.

研究成果: Article › 同行評審

開啟存取

6 引文斯高帕斯（Scopus）

Cd40 pathway and il-2 expression mediate the differential outcome of colorectal cancer patients with different csf1r c.1085 genotypes

Yeh, Y. M., Lin, P. C., Su, W. C. & Shen, M. R., 2021 11月 1, 於: International journal of molecular sciences. 22, 22, 12565.

研究成果: Article › 同行評審

開啟存取

5 引文斯高帕斯（Scopus）

Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer

Chan, R. H., Lin, P. C., Chen, S. H., Lin, S. C., Chen, P. C., Lin, B. W., Shen, M. R. & Yeh, Y. M., 2021 3月 19, 於: Frontiers in Oncology. 11, 589673.

研究成果: Article › 同行評審

開啟存取

8 引文斯高帕斯（Scopus）

Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer

Lee, C. T., Chow, N. H., Chen, Y. L., Ho, C. L., Yeh, Y. M., Lin, S. C., Lin, P. C., Lin, B. W., Chu, C. A., Tsai, H. W. & Lee, J. C., 2021 1月, 於: Pathology Research and Practice. 217, 153288.

研究成果: Article › 同行評審

開啟存取

11 引文斯高帕斯（Scopus）

Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients

Lin, P. C., Chen, H. O., Lee, C. J., Yeh, Y. M., Shen, M. R. & Chiang, J. H., 2021 12月, 於: Human Genomics. 15, 1, 3.

研究成果: Article › 同行評審

開啟存取

5 引文斯高帕斯（Scopus）

Comprehensively exploring the mutational landscape and patterns of genomic evolution in hypermutated cancers

Lin, P. C., Yeh, Y. M., Hsu, H. P., Chan, R. H., Lin, B. W., Chen, P. C., Pan, C. C., Hsu, K. F., Hsiao, J. R., Shan, Y. S. & Shen, M. R., 2021 9月 1, 於: Cancers. 13, 17, 4317.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Met mutation is a potential therapeutic target for advanced endometrial cancer

Yeh, Y. M., Wu, P. Y., Lin, P. C., Su, P. F., Hsu, Y. T., Hsu, K. F. & Shen, M. R., 2021 8月 2, 於: Cancers. 13, 16, 4231.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers

Chang, K. Y., Chiang, N. J., Wu, S. Y., Yen, C. J., Chen, S. H., Yeh, Y. M., Li, C. F., Feng, X., Wu, K., Johnston, A., Bomalaski, J. S., Wu, B. W., Gao, J., Subudhi, S. K., Kaseb, A. O., Blando, J. M., Yadav, S. S., Szlosarek, P. W. & Chen, L. T., 2021, 於: OncoImmunology. 10, 1, 1943253.

研究成果: Article › 同行評審

開啟存取

24 引文斯高帕斯（Scopus）

Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy

Lin, P. C., Yeh, Y. M., Chan, R. H., Lin, B. W., Chen, P. C., Pan, C. C. & Shen, M. R., 2021 12月, 於: BMC cancer. 21, 1, 217.

研究成果: Article › 同行評審

開啟存取

9 引文斯高帕斯（Scopus）

Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy

Chen, S. J., Chen, L. H., Yeh, Y. M., Lin, C. C. K., Lin, P. C., Huang, H. W., Shen, M. R., Lin, B. W., Lee, J. C., Lee, C-C., Lee, Y. F., Chiang, H. C. & Chang, J-Y., 2021 3月 4, 於: Theranostics. 11, 10, p. 4672-4687 16 p.

研究成果: Article › 同行評審

開啟存取

12 引文斯高帕斯（Scopus）

2020

A Simplified Diagnostic Classification Scheme of Chemotherapy-Induced Peripheral Neuropathy

Huang, H. W., Wu, P. Y., Su, P. F., Li, C. I., Yeh, Y. M., Lin, P. C., Hsu, K. F., Shen, M. R., Chang, J. Y. & Lin, C. C. K., 2020, 於: Disease Markers. 2020, 3402108.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients with Advanced Melanoma: A Systematic Review and Network Meta-analysis

Chang, C. Y., Park, H., Malone, D. C., Wang, C. Y., Wilson, D. L., Yeh, Y. M., Van Boemmel-Wegmann, S. & Lo-Ciganic, W. H., 2020 3月 25, 於: JAMA network open. 3, 3, e201611.

研究成果: Article › 同行評審

開啟存取

80 引文斯高帕斯（Scopus）

Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer

Lin, P. C., Yeh, Y. M., Lin, B. W., Lin, S. C., Chan, R. H., Chen, P. C. & Shen, M. R., 2020 10月 29, 於: Frontiers in Oncology. 10, 588557.

研究成果: Article › 同行評審

開啟存取

8 引文斯高帕斯（Scopus）

Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Phase III NALA trial

NALA Investigators, 2020 9月 20, 於: Journal of Clinical Oncology. 38, 27, p. 3138-3149 12 p.

研究成果: Article › 同行評審

開啟存取

412 引文斯高帕斯（Scopus）

Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy

Chen, L. H., Yeh, Y. M., Chen, Y. F., Hsu, Y. H., Wang, H. H., Lin, P. C., Chang, L. Y., Lin, C. C. K., Chang, M. S. & Shen, M. R., 2020 6月 1, 於: Pain. 161, 6, p. 1237-1254 18 p.

研究成果: Article › 同行評審

27 引文斯高帕斯（Scopus）

2019

Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: From next-generation sequencing to clinical significance

Yeh, Y. M., Lee, C. H., Chen, S. H., Lee, C. T., Lin, B. W., Lin, S. C., Chan, R. H., Lee, J. C., Shen, M. R. & Lin, P. C., 2019, 於: Cancer Management and Research. 11, p. 7867-7875 9 p.

研究成果: Article › 同行評審

開啟存取

7 引文斯高帕斯（Scopus）

Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol

Chen, S. H., Tsai, H. L., Jiang, J. K., Sung, Y. C., Huang, C. W., Yeh, Y. M., Chen, L. T. & Wang, J. Y., 2019 6月 28, 於: BMC cancer. 19, 1, 640.

研究成果: Article › 同行評審

開啟存取

5 引文斯高帕斯（Scopus）

Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer

Lin, P. C., Yeh, Y. M., Wu, P. Y., Hsu, K. F., Chang, J. Y. & Shen, M. R., 2019 12月 1, 於: Scientific reports. 9, 1, 3931.

研究成果: Article › 同行評審

開啟存取

17 引文斯高帕斯（Scopus）

2017

Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy

Chen, Y. F., Chen, L. H., Yeh, Y. M., Wu, P. Y., Chen, Y. F., Chang, L. Y., Chang, J. Y. & Shen, M. R., 2017 3月 28, 於: Scientific reports. 7, 45366.

研究成果: Article › 同行評審

開啟存取

39 引文斯高帕斯（Scopus）

The c.1085A>G genetic variant of CSF1R gene regulates tumor immunity by altering the proliferation, polarization, and function of macrophages

Yeh, Y. M., Hsu, S. J., Lin, P. C., Hsu, K. F., Wu, P. Y., Su, W. C., Chang, J. Y. & Shen, M. R., 2017 10月 15, 於: Clinical Cancer Research. 23, 20, p. 6021-6030 10 p.

研究成果: Article › 同行評審

開啟存取

17 引文斯高帕斯（Scopus）

2015

MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy

Hsu, T. I., Lin, S. C., Lu, P. S., Chang, W. C., Hung, C. Y., Yeh, Y. M., Su, W. C., Liao, P. C. & Hung, J. J., 2015 2月 12, 於: Oncogene. 34, 7, p. 826-837 12 p.

研究成果: Article › 同行評審

開啟存取

34 引文斯高帕斯（Scopus）

2014

Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease

Chang, K. C., Wang, Y. C., Hung, L. Y., Huang, W. T., Tsou, J. H., M Jones, D., Song, H. L., Yeh, Y. M., Kao, L. Y. & Medeiros, L. J., 2014 6月, 於: Modern Pathology. 27, 6, p. 823-831 9 p.

研究成果: Article › 同行評審

開啟存取

73 引文斯高帕斯（Scopus）

2013

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy

Chang, C. H., Hsiao, C. F., Yeh, Y. M., Chang, G. C., Tsai, Y. H., Chen, Y. M., Huang, M. S., Chen, H. L., Li, Y. J., Yang, P. C., Chen, C. J., Hsiung, C. A. & Su, W. C., 2013 5月 1, 於: International Journal of Cancer. 132, 9, p. 1977-1985 9 p.

研究成果: Article › 同行評審

153 引文斯高帕斯（Scopus）

Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma

Chang, K. C., Chang, W. C., Chang, Y., Hung, L. Y., Lai, C. H., Yeh, Y. M., Chou, Y. W. & Chen, C. H., 2013 11月 6, 於: PloS one. 8, 11, e79863.

研究成果: Article › 同行評審

開啟存取

15 引文斯高帕斯（Scopus）

Rituximab-induced Severe Pulmonary Disease

貢獻的翻譯標題: Rituximab引致嚴重肺部疾病Chung, W-P., Wu, S-Y., Yeh, Y-M., Chen, Y-P., Chiu, W-H., Lin, P-C., Su, W-P., Yen, C-J., Su, W-C. & Chen, T-Y., 2013 6月, 於: Journal of Cancer Research and Practice. 29, 2, p. 79-83

研究成果: Article › 同行評審

2012

Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of Sp1 to inhibit lung cancer growth

Hsu, T. I., Wang, M. C., Chen, S. Y., Huang, S. T., Yeh, Y. M., Su, W. C., Chang, W. C. & Hung, J. J., 2012 12月, 於: Molecular Pharmacology. 82, 6, p. 1115-1128 14 p.

研究成果: Article › 同行評審